Abraham Morgentaler
#162,461
Most Influential Person Now
Researcher
Abraham Morgentaler's AcademicInfluence.com Rankings
Abraham Morgentalerphilosophy Degrees
Philosophy
#9420
World Rank
#12974
Historical Rank
Logic
#6400
World Rank
#7915
Historical Rank
Download Badge
Philosophy
Why Is Abraham Morgentaler Influential?
(Suggest an Edit or Addition)Abraham Morgentaler's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Risks of testosterone-replacement therapy and recommendations for monitoring. (2004) (685)
- Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. (2009) (388)
- Is low serum free testosterone a marker for high grade prostate cancer? (2000) (310)
- Occult prostate cancer in men with low serum testosterone levels. (1996) (270)
- Heat stress causes testicular germ cell apoptosis in adult mice. (1997) (260)
- Testosterone and prostate cancer: an historical perspective on a modern myth. (2006) (246)
- Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men (2015) (244)
- Endocrine aspects of male sexual dysfunctions. (2010) (208)
- Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less. (2006) (207)
- Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia. (2003) (178)
- Testosterone therapy and cardiovascular risk: advances and controversies. (2015) (175)
- Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores. (2017) (149)
- p53-mediated germ cell quality control in spermatogenesis. (1998) (147)
- A new era of testosterone and prostate cancer: from physiology to clinical implications. (2014) (144)
- Experimental cryptorchidism induces testicular germ cell apoptosis by p53-dependent and -independent pathways in mice. (1998) (144)
- Testosterone deficiency. (2011) (138)
- Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth (2009) (129)
- Testosterone therapy in men with untreated prostate cancer. (2011) (128)
- Mechanical reliability and safety of, and patient satisfaction with the Ambicor inflatable penile prosthesis: results of a 2 center study. (2001) (128)
- Management of the impacted ureteral calculus. (1990) (127)
- The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men. (2015) (125)
- Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). (2016) (121)
- Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men (2014) (121)
- Testosterone and prostate cancer: revisiting old paradigms. (2009) (118)
- Spontaneous perinephric and subcapsular renal hemorrhage: evaluation with CT, US, and angiography. (1989) (118)
- P53 and Fas are sequential mechanisms of testicular germ cell apoptosis. (2002) (106)
- Penile rehabilitation should become the norm for radical prostatectomy patients. (2007) (105)
- Vascular permeability factor (vascular endothelial growth factor) is strongly expressed in the normal male genital tract and is present in substantial quantities in semen. (1995) (91)
- Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy. (2015) (89)
- Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions. (2016) (88)
- 3H‐Estradiol, 3H‐Testosterone and 3H‐Dihydrotestosterone localization in the brain of the lizard Anolis carolinensis: An autoradiographic study (1979) (84)
- Symptomatic response rates to testosterone therapy and the likelihood of completing 12 months of therapy in clinical practice. (2010) (83)
- Outcomes and satisfaction rates for the redesigned 2-piece penile prosthesis. (2007) (77)
- Testosterone replacement therapy and prostate cancer. (2007) (75)
- Do Androgens Modulate the Pathophysiological Pathways of Inflammation? Appraising the Contemporary Evidence (2018) (75)
- Prostate cancer incidence in orchidectomised male‐to‐female transsexual persons treated with oestrogens (2014) (75)
- Testosterone Therapy in Men With Prostate Cancer. (2016) (73)
- Wide variability in laboratory reference values for serum testosterone. (2006) (71)
- Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). (2017) (68)
- Testosterone therapy in men with prostate cancer: scientific and ethical considerations. (2009) (67)
- The association of time of day and serum testosterone concentration in a large screening population (2007) (64)
- Testosterone deficiency and prostate cancer: emerging recognition of an important and troubling relationship. (2007) (62)
- Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy (2006) (59)
- Congenital anomalies of the vas deferens, epididymis, and seminal vesicles. (1997) (58)
- Classics of urology: a half century history of the most frequently cited articles (1955-2009). (2010) (56)
- Testis and temperature: an historical, clinical, and research perspective. (1999) (55)
- Sexual Rehabilitation After Treatment for Prostate Cancer-Part 1: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). (2017) (55)
- Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results (2015) (55)
- The practical management of testosterone deficiency in men (2015) (52)
- Death by testosterone? We think not! (2014) (52)
- Long‐acting testosterone injections for treatment of testosterone deficiency after brachytherapy for prostate cancer (2014) (51)
- Testosterone deficiency and Peyronie's disease: pilot data suggesting a significant relationship. (2009) (49)
- Low free testosterone levels predict disease reclassification in men with prostate cancer undergoing active surveillance (2014) (49)
- The value of pituitary magnetic resonance imaging in men with hypogonadism. (2003) (49)
- Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study. (2008) (48)
- Effects of intracranial implantation of oestradiol and dihydrotestosterone on the sexual behaviour of the lizard Anolis carolinensis. (1979) (48)
- The ratio of serum testosterone-to-prostate specific antigen predicts prostate cancer in hypogonadal men. (2008) (47)
- Influence of testicular carcinoma on ipsilateral spermatogenesis. (1992) (47)
- Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer. (2015) (45)
- Commentary: Who is a candidate for testosterone therapy? A synthesis of international expert opinions. (2014) (44)
- Rational approach to evaluation and management of spontaneous perirenal hemorrhage. (1990) (43)
- A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(®)) insertion. (2012) (42)
- Screening and Monitoring in Men Prescribed Testosterone Therapy in the U.S., 2001–2010 (2015) (41)
- Factors influencing prostate-specific antigen response among men treated with testosterone therapy for 6 months. (2014) (41)
- Temperature-mediated germ cell loss in the testis is associated with altered expression of the cell-cycle regulator p53. (1997) (40)
- Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole (2004) (39)
- Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine. (2019) (38)
- Testosterone and cardiovascular risk: world’s experts take unprecedented action to correct misinformation (2014) (38)
- Sperm morphology and in vitro fertilization outcome: a direct comparison of World Health Organization and strict criteria methodologies. (1995) (38)
- Goodbye androgen hypothesis, hello saturation model. (2012) (37)
- Bone mineral density and response to treatment in men younger than 50 years with testosterone deficiency and sexual dysfunction or infertility. (2014) (37)
- Quality of life following simultaneous placement of penile prosthesis with radical prostatectomy. (2005) (36)
- Estrogens in men: clinical implications for sexual function and the treatment of testosterone deficiency. (2012) (35)
- Commentary: Guideline for male testosterone therapy: a clinician's perspective. (2007) (35)
- The NERI Hypogonadism Screener: psychometric validation in male patients and controls (2011) (35)
- Studies on prostatic cancer I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate by Charles Huggins and Clarence V. Hodges. (2010) (35)
- Controversies and Advances With Testosterone Therapy: A 40-Year Perspective. (2016) (33)
- Guilt by association: a historical perspective on Huggins, testosterone therapy, and prostate cancer. (2008) (33)
- p53 is associated with the nuclear envelope in mouse testis. (1997) (33)
- A 66-year-old man with sexual dysfunction. (2004) (33)
- Testosterone, cardiovascular risk, and hormonophobia. (2014) (33)
- Immediate sexual rehabilitation by simultaneous placement of penile prosthesis in patients undergoing radical prostatectomy: initial results in 50 patients. (1997) (32)
- Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone. (2007) (30)
- Comparison of free testosterone results by analog radioimmunoassay and calculated free testosterone in an ambulatory clinical population. (2010) (30)
- Systematic Literature Review of the Epidemiology of Nongenetic Forms of Hypogonadism in Adult Males (2014) (30)
- Free testosterone by direct and calculated measurement versus equilibrium dialysis in a clinical population (2013) (29)
- The effect of testicular nongerm cell tumors on local spermatogenesis. (1994) (28)
- Two years of testosterone therapy associated with decline in prostate-specific antigen in a man with untreated prostate cancer. (2009) (28)
- LOW TESTOSTERONE LEVELS ARE RELATED TO POOR PROGNOSIS FACTORS IN MEN WITH PROSTATE CANCER PRIOR TO TREATMENT (2012) (27)
- Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: Use of a novel noninferiority study design. (2006) (27)
- Hypogonadism in the man with erectile dysfunction: What to look for and when to treat (2005) (26)
- Turning conventional wisdom upside‐down (2011) (26)
- Testosterone and prostate cancer: what are the risks for middle-aged men? (2011) (26)
- Testosterone therapy for men at risk for or with history of prostate cancer (2006) (25)
- Clinical and Demographic Correlates of Ejaculatory Dysfunctions Other Than Premature Ejaculation: A Prospective, Observational Study. (2015) (24)
- Andrology: Testosterone and cardiovascular risk—deciphering the statistics (2014) (24)
- Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations (2015) (23)
- Penile mass caused by the newly described organism Mycobacterium celatum. (1996) (22)
- Is testosterone a friend or a foe of the prostate? (2011) (21)
- Testosterone and prostate safety. (2009) (20)
- Testosterone deficiency and cardiovascular mortality (2014) (20)
- Deaths and cardiovascular events in men receiving testosterone. (2014) (20)
- Metastatic testicular teratoma invading the inferior vena cava. (1988) (19)
- Delayed Ejaculation and Associated Complaints: Relationship to Ejaculation Times and Serum Testosterone Levels. (2017) (18)
- Assessing symptoms of hypogonadism by self-administered questionnaire: qualitative findings in patients and controls (2009) (18)
- The History of Testosterone and the Evolution of its Therapeutic Potential. (2020) (18)
- Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men (2021) (16)
- Testosterone and cardiovascular disease – the controversy and the facts (2015) (16)
- Risk of Testosterone Flare in the Era of the Saturation Model: One More Historical Myth. (2017) (16)
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. (2021) (16)
- Protein differences between normal and oligospermic human sperm demonstrated by two-dimensional gel electrophoresis. (1990) (15)
- Testosterone replacement therapy and prostate risks: where's the beef? (2006) (14)
- The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk (2018) (14)
- Serum Concentrations of Sex Hormone-binding Globulin Vary Widely in Younger and Older Men: Clinical Data from a Men's Health Practice. (2017) (13)
- Rapidly Shifting Concepts Regarding Androgens and Prostate Cancer (2009) (13)
- A self-expanding prostatic stent for bladder outlet obstruction in high risk patients. (1993) (13)
- Heat-induced testicular apoptosis occurs independently of hormonal depletion (1998) (13)
- Successful treatment of Post-orgasmic illness syndrome with human chorionic gonadotropin (2019) (12)
- International expert consensus conference on testosterone deficiency and its treatment held in Prague, Czech Republic (2015) (12)
- Partial duplication of the vas deferens. (1998) (12)
- Rapid high resolution two‐dimensional electrophoresis of human sperm proteins (1992) (12)
- Does testosterone therapy increase the risk of prostate cancer? (2008) (11)
- Double trouble: Co‐occurrence of testosterone deficiency and body fatness associated with all‐cause mortality in US men (2018) (11)
- Ureteral pseudodiverticulosis: the case for the retrograde urogram. (1996) (11)
- Absent Diurnal Variation in Serum Testosterone in Young Men With Testosterone Deficiency. (2020) (11)
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women (2021) (11)
- Testosterone Therapy and Prostate Cancer. (2016) (9)
- Should hypogonadal men with prostate cancer receive testosterone? (2010) (9)
- Does testosterone increase the risk of a cardiovascular event? (2014) (9)
- Words of wisdom. Re: Adverse events associated with testosterone administration. (2011) (9)
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women (2021) (9)
- Part 2: Surgical palliation of advanced illness: what's new, what's helpful. (2005) (9)
- The effect of aging on spermatogenesis and pregnancy outcomes. (2008) (9)
- Male impotence (2000) (9)
- Testosterone for Life: Recharge Your Vitality, Sex Drive, Muscle Mass, and Overall Health (2008) (9)
- Dutasteride in men receiving testosterone therapy: a randomised, double‐blind study (2015) (8)
- Safety of testosterone therapy in men with prostate cancer (2019) (8)
- Testosterone Therapy in Men with Biochemical Recurrence and Metastatic Prostate Cancer: Initial Observations (2021) (8)
- Testosterone Therapy Can be Given to Men with No Concern that it will Promote Prostate Cancer Development or Progression: Pro. (2016) (7)
- Male and Female Sexual Dysfunction in a Rapidly Changing Cultural Environment: Addressing Gender Equality versus Equivalence in the Bedroom. (2016) (7)
- Canadian Urological Association clinical practice guideline on testosterone deficiency in men: Evidence-based Q&A. (2021) (7)
- The Viagra Myth: The Surprising Impact On Love And Relationships (2003) (7)
- Quality-of-life after penile prosthesis placed at radical prostatectomy (2000) (7)
- Influence of baseline serum testosterone on changes in body composition in response to testosterone therapy. (2012) (7)
- Medical hypothesis: loss of the endocrine function of the prostate is important to the pathophysiology of postprostatectomy erectile dysfunction. (2014) (7)
- Treatment of an impacted fecalith with electrohydraulic lithotripsy. (1990) (6)
- Outcomes with the "V" implantation technique vs. standard technique for testosterone pellet therapy. (2011) (6)
- Testosterone therapy in men with prostate cancer: scientific and ethical considerations. (2009) (6)
- Y chromosome microdeletions and male infertility: who should be tested and why? (2006) (6)
- New concepts regarding the relationship of testosterone and prostate cancer. (2007) (6)
- 1 Letter From the Co-Chairs (2008) (6)
- Overselling hysteria (2017) (6)
- Design considerations in penile prostheses: the American Medical Systems product line. (1997) (6)
- The Evaluation and Management of Testosterone Deficiency: the New Frontier in Urology and Men’s Health (2013) (5)
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results. (2019) (5)
- Cultural biases and scientific squabbles: The challenges to acceptance of testosterone therapy as a mainstream medical treatment (2007) (5)
- Initial Clinical Experience With Testosterone Undecanoate Therapy (AVEED) in Men With Testosterone Deficiency in the United States. (2017) (5)
- What’s Testosterone Got to Do with It? A Critical Assessment of the Contribution of Testosterone to Gender Disparities in COVID-19 Infections and Deaths (2021) (5)
- Detached ciliary tufts in the epididymis: a lesson in applied anatomy. (1995) (5)
- Part 3: surgical palliation of advanced illness: what's new, what's helpful. (2005) (5)
- Reply to A. Edward Friedman's Letter to the Editor re: Abraham Morgentaler, Abdulmaged M. Traish. Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth. Eur Urol 2009;55:310–21 (2009) (4)
- Nerve growth factor as a new treatment for testosterone deficiency? (2018) (4)
- PRESERVATION OF NORMAL CONCENTRATIONS OF PITUITARY GONADOTROPINS DESPITE ACHIEVEMENT OF NORMAL SERUM TESTOTERONE LEVELS IN HYPOGONADAL MEN TREATED WITH A 4.5% NASAL TESTOSTERONE GEL: MP89‐06 (2017) (4)
- 1376 PSA AND FOLLOW-UP BIOPSY RESULTS IN MEN WHO RECEIVED TESTOSTERONE THERAPY WHILE ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER (2010) (4)
- 1324: Diurnal Serum Testosterone Variation in Aging Men: Cross-Sectional Analysis from a Large National Screening Program Reveals Only a Modest Decline Beginning in the Mid-Afternoon (2006) (4)
- Spontaneous corporeal herniation of the penis: a new abnormality of the tunica albuginea? (1995) (4)
- Re: Prostate cancer in men using testosterone supplementation. F. D. Gaylis, D. W. Lin, J. M. Ignatoff, C. L. Amling, R. F. Tutrone and D. J. Cosgrove. (2006) (4)
- Effects of chronic administration of dehydroepiandrosterone on serum testosterone levels and prostatic tissue in rats. (2003) (4)
- A Critique of the AUA Guidelines on Testosterone Deficiency. (2019) (3)
- The Prevalence, Incidence, And Treatment Rates Of Hypogonadism In Men Across Geographies: A Systematic Literature Review (2013) (3)
- Will I have a heart attack or stroke if I take testosterone therapy? (2014) (3)
- FREE AND TOTAL TESTOSTERONE IN THE EVALUATION OF PROSTATE CANCER: DOES LOW FREE TESTOSTERONE PREDISPOSE TO MORE AGGRESSIVE DISEASE? (1999) (3)
- Pathologic Features of Occult Prostatic Carcinoma in Hypogonadal Men (2000) (3)
- Pharmacokinetics and drying time of testosterone 2% gel in men with hypogonadism: a multicenter, open-label, single-arm trial (2014) (3)
- Temperature‐dependent expression of a 95 kD protein in rat testis (2009) (3)
- Re: effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. (2008) (3)
- MP17-03 RECURRENCE RATES FOLLOWING TESTOSTERONE THERAPY IN A LARGE CLINICAL COHORT OF MEN WITH PROSTATE CANCER (2018) (2)
- Strategies for Testosterone Therapy in Men with Metastatic Prostate Cancer in Clinical Practice: Introducing Modified Bipolar Androgen Therapy (2020) (2)
- Fundamental Concepts Regarding Testosterone Deficiency and Treatment (2016) (2)
- RE: Testosterone treatment is a potent tumor promoter for the rat prostate. (2015) (2)
- Why Men Fake It: The Totally Unexpected Truth About Men and Sex (2013) (2)
- MP48-08 SAFETY OF TESTOSTERONE THERAPY IN MEN WITH PROSTATE CANCER (2014) (2)
- Destroying the Myth About Testosterone Replacement and Prostate Cancer By (2008) (2)
- Re: Masashi Yano, Takashi Imamoto, Hiroyoshi Suzuki et Al. The clinical potential of pretreatment serum testosterone level to improve the efficiency of prostate cancer screening. Eur urol 2007;51:375-80. (2007) (2)
- Andrology: Testosterone reference ranges and diagnosis of testosterone deficiency (2017) (2)
- Cardiovascular and Cerebrovascular Safety of Testosterone Therapy. (2019) (2)
- SERUM TESTOSTERONE IS ASSOCIATED WITH AGGRESSIVE PROSTATE CANCER IN OLDER MEN: RESULTS FROM THE BALTIMORE LONGITUDINAL STUDY OF AGING (2010) (2)
- Phleboliths in varicoceles presenting as spermatic cord mass. (2006) (2)
- Association of low testosterone with changes in non-cardiovascular biomarkers in adult men (2019) (2)
- Causality and association--more than just different shades of gray. (1997) (2)
- 107 Preservation of Normal Concentration of Pituitary Gonadotropins Despite Achievement of Normal Serum Testosterone Levels in Hypogonadal Men Treated with 4.5% Nasal Testosterone Gel (Natesto) (2018) (2)
- Curiosity and other attitudes towards sex robots: Results of an online survey (2021) (2)
- Optimizing testosterone replacement therapy in hypogonadal men (2007) (2)
- Vasectomy and increased risk of prostate cancer. (1993) (1)
- Erectile dysfunction A precursor to cardiovascular (2009) (1)
- Letter to the editor: Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer (2020) (1)
- 664 TESTOSTERONE THERAPY IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER (2013) (1)
- 132 Initial Experience with Testosterone Therapy in Selected Men with Advanced or Metastatic Prostate Cancer (2018) (1)
- RE: Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer (2013) (1)
- Examining Male Predominance of Severe COVID-19 Outcomes: A Systematic Review (2022) (1)
- How the rise of testosterone therapy in men was inspired by lizard research with David Crews. (2021) (1)
- Re: The Interpretation of Serum Prostate Specific Antigen in Men Receiving 5α-Reductase Inhibitors: A Review and Clinical Recommendations: L. S. Marks, G. L. Andriole, J. M. Fitzpatrick, C. C. Schulman and C. G. Roehrborn J Urol 2006; 176: 868–874 (2007) (1)
- Re: The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendations. (2007) (1)
- Androgen Therapy in Women with Testosterone Insufficiency: Looking Back and Looking Ahead (2022) (1)
- The consensus recommendations of a group of international experts on the fundamental concepts related to the issues of testosterone deficiency and its treatment. (2016) (1)
- The Testosterone Trials: What the Results Mean for Healthcare Providers and for Science (2017) (1)
- FIRST LONG ACTING TESTOSTERONE UNDECANOATE INJECTION TO TREAT MALE HYPOGONADISM: 21 MONTH SAFETY AND EFFICACY OUTCOMES (2009) (1)
- Experience with the penile prosthesis and artificial urinary sphincter. (1995) (1)
- Testosterone Boosters: How Real Are Their Effects? (2022) (1)
- Technical advances in penile prostheses. (2006) (1)
- Testosterone and cardiovascular disease – what is the story? (2016) (1)
- Male impotence (1999) (1)
- Augmenting Intralesional Collagenase Treatment with Testosterone Therapy Provides Greater Self-Assessed Improvement in Penile Curvature due to Peyronie's Disease (2020) (1)
- Re: Unilateral unitary inflatable penile prosthesis to correct impaired tumescence and severe penile deformity resulting from traumatic rupture of 1 corpus cavernosum. (1995) (1)
- Collaborative Review – Prostate Cancer Testosterone and Prostate Cancer : Revisiting Old Paradigms (2009) (1)
- Testosterone replacement therapy: Benefits, risks, and controversies (2004) (1)
- 1230 CLINICAL EFFICACY OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM IN THE TREATMENT OF PEYRONIE'S DISEASE BY BASELINE PENILE CURVATURE SEVERITY STRATUM: RESULTS FROM TWO LARGE DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDIES (2013) (0)
- Data fail to support concerns over T therapy, CV risk (2014) (0)
- A Multi-Institutional Observational Study on Testosterone Levels After Testosterone Pellet (Testopel TM) Insertion (2010) (0)
- Androgen Supplementation in the Prostate Cancer Patient (2009) (0)
- Motile organisms in the epididymis? (1998) (0)
- 1383 ELEVATED ESTRADIOL LEVLES ARE NOT ASSOCIATED WITH SUPRESSION OF TESTOSTERONE IN MEN WITH TESTOSTERONE DEFICIENCY (2012) (0)
- Male Sexual Dysfunction—Reply (2004) (0)
- [Patient with testosterone deficit syndrome after radical prostatectomy]. (2013) (0)
- Aberrant Supply of the Common Penile Artery from an Inferior Epigastric/External Pudendal Artery Trunk: Radiological and Urological Implications (1997) (0)
- QUALITY-OF-LIFE EFFECTS OF IMMEDIATE SEXUAL REHABILITATION FOR PROSTATE CANCER (1999) (0)
- Erectile dysfunction. (2003) (0)
- 693: Does Initial Serum Testosterone Influence the Degree of Biochemical Changes Seen with Testosterone Replacement Therapy? (2006) (0)
- IS IT NECESSARY TO PREVENT TESTOSTERONE FLARE? A SYSTEMATIC REVIEW AND REASSESSMENT IN THE ERA OF THE SATURATION MODEL: MP14‐10 (2017) (0)
- 005 Testosterone Therapy Improves Response to Intralesional Collagenase (XIAFLEX®) in Men with Peyronie’s Disease and Testosterone Deficiency (2019) (0)
- Male sexual dysfunction: a revolution (1998) (0)
- Origins of the Concern The basis for the fear that testosterone therapy increases the risk of prostate cancer originated with the work of (2011) (0)
- Response to: Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men (2008) (0)
- Introducing Androgens: Clinical Research and Therapeutics (2020) (0)
- Keep It Up (2013) (0)
- Current diagnosis and management of impotence : Endocrinology (1991) (0)
- Interview with Dr. Abraham Morgentaler (2020) (0)
- Nourishing Our Future: Supporting Breastfeeding in the Primary Care Setting (2008) (0)
- Management of impending sterility (1996) (0)
- 1523 TESTOSTERONE THERAPY AFTER RADIATION THERAPY FOR PROSTATE CANCER (2013) (0)
- Platinum Priority – Editorial and Reply from Authors Goodbye Androgen Hypothesis , Hello Saturation Model (2012) (0)
- Hyponatremic encephalopathy after endometrial ablation. (1994) (0)
- Testosterone therapy and medical hysteria (2018) (0)
- 029 Improved Maintenance on Index Therapy and Decreased Risk of Hypertension Among Men Treated with Injections of Long-Acting Testosterone Undecanoate Compared with Short-Acting Testosterone Cypionate (2021) (0)
- 065 Absent Diurnal Variation In Serum Testosterone Observed In Men With Baseline Low Testosterone (2019) (0)
- 024 Serum Concentrations of SHBG Vary Widely in Younger and Older Men: Clinical Data From a Men's Health Practice (2017) (0)
- New concepts regarding testosterone and prostate cancer: a breath of fresh air. (2014) (0)
- Understanding the Controversy Regarding Treatment of Age-Related Testosterone Deficiency (2021) (0)
- Testosterone Therapy in a Man with Intermediate-risk Prostate Cancer: Pro. (2017) (0)
- Re : Female Sexual Function before and after Bariatric Surgery : A Cross-Sectional Study and Review of Literature (2015) (0)
- TESTOSTERONE AND CARDIOVASCULAR RISK the FDA and to the European Medicines (2015) (0)
- ANDROGENS: Interview with Paresh Dandona, MD (2021) (0)
- Correction to: Testosterone Therapy and Prostate Cancer (2018) (0)
- Benefits and Risks of Testosterone Therapy in Men With Testosterone Deficiency (2019) (0)
- 1497 A MULTI-INSTITUTIONAL OBSERVATIONAL STUDY ON TESTOSTERONE LEVELS AFTER TESTOSTERONE PELLET (TESTOPEL™) INSERTION (2010) (0)
- Comparison of Patterns of Use and Clinical Outcomes Between Injections of Testosterone Undecanoate and Testosterone Cypionate: An Electronic Health Record Cohort Study (2022) (0)
- Testosterone therapy's big week: One urologist's perspective (2017) (0)
- Editorial Comment. (2022) (0)
- Male sexual dysfunction. Author's reply (2004) (0)
- 1675 EFFECT OF LONG-ACTING TESTOSTERONE INJECTIONS FOR TREATMENT OF HYPOGONADISM AFTER BRACHYTHERAPY FOR PROSTATE CANCER (2011) (0)
- Use of testosterone therapy in hypogonadal men with prostate cancer (2010) (0)
- 1180: The Influence of Age and Initial Prostate Volume on the PSA Response to Testosterone Therapy (2007) (0)
- Effects of Oral Testosterone Undecanoate (Kyzatrex) Versus Testosterone Gel (Androgel) on Long-Term (to 12 Months) Blood Pressure Levels (2022) (0)
- HYPOGONADISM: PREVALENCE, DIAGNOSIS, PHYSIOLOGICAL ASPECTS, AND CAUSES (2006) (0)
- 1266: A Multi-Center Study: Safety, Efficacy and Patient Satisfaction Results of the Two-Piece Ambicor™ Inflatable Penile Prosthesis (IPP) (2005) (0)
- Men's Health: Controversies in testosterone replacement therapy (2004) (0)
- 1241: The Use of Current Testosterone Reference Ranges is a Major Obstacle to the Diagnosis of Hypogonadism: A Survey of Academic and Community Clinical Laboratories (2005) (0)
- Temperature dependent protein expression in rat testis (1991) (0)
- Current Diagnostic Criteria for Testosterone Deficiency Are Inadequate. (2018) (0)
- Recognizing the True Value of Testosterone Therapy in Health Care (2022) (0)
- 023 Prevalence of Testosterone Deficiency in Men Treated with Collagenase Clostridium Histolyticum (Xiaflex) for Peyronie's Disease (2017) (0)
- Highlights from the 20th International Prostate Cancer Update (2010) (0)
- Preformation under the microscope Clara Pinto-Correia The Ovary of Eve (1998) (0)
- Hormonal Evaluation and Therapy in Erectile Dysfunction (2011) (0)
- Response and Rebuttal to Editorial Comment on: Clinical and Demographic Correlates of Ejaculatory Dysfunctions Other than Premature Ejaculation: A Prospective, Observational Study. (2015) (0)
- Original but not sinful Malcom Potts Roger Short (1999) (0)
- 302 Safety of Testosterone Therapy in Octogenarians: An Increasingly Important Demographic in 2017 (2018) (0)
- Current diagnosis and management of impotence. (1991) (0)
- How Far We Have Come: Testosterone and Sexual Dysfunction (2022) (0)
- Reply to Julia Klap and Kevin R. Loughlin's letter to the editor re: Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol 2014;65:115-23. (2014) (0)
- 1676 INFLUENCE OF BASELINE TESTOSTERONE LEVELS ON BODY COMPOSITION CHANGES WITH TESTOSTERONE THERAPY (2011) (0)
- 340 Safety of Testosterone Therapy in a Large Clinical Cohort of Men with Prostate Cancer (2018) (0)
- 157 Early Clinical Experience with Testosterone Undecanoate (AVEED) in Testosterone-Deficient Men (2017) (0)
- Testosterone Therapy in the Male Cancer Patient (2011) (0)
- TESTOSTERONE DEFICIENCY AS A POSSIBLE ETIOLOGIC FACTOR IN PEYRONIE'S DISEASE (2009) (0)
- Obese Men: A Randomized Controlled Trial Effect of Lifestyle Changes on Erectile Dysfunction in (2009) (0)
- Case 2: The Patient with Hypogonadism and Multiple Co-morbidities (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Abraham Morgentaler?
Abraham Morgentaler is affiliated with the following schools:
